Tech Company Financing Transactions

PhaseRx Funding Round

PhaseRx, based in Seattle, raised $1.5 million in funding from private investors.

Transaction Overview

Company Name
Announced On
12/26/2012
Transaction Type
Debt
Amount
$1,500,016
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
410 West Harrison St. 300
Seattle, WA 98119
USA
Email Address
Overview
PhaseRx (NASDAQ: PZRX) is an RNAi delivery technology company developing a breakthrough polymer-based system that enables the systemic delivery of RNAi-based drugs and potentially other macromolecules as therapeutic products.
Profile
PhaseRx LinkedIn Company Profile
Social Media
PhaseRx Company Twitter Account
Company News
PhaseRx News
Facebook
PhaseRx on Facebook
YouTube
PhaseRx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Overell
  Robert Overell LinkedIn Profile  Robert Overell Twitter Account  Robert Overell News  Robert Overell on Facebook
VP - Bus. Development
Michael Houston
  Michael Houston LinkedIn Profile  Michael Houston Twitter Account  Michael Houston News  Michael Houston on Facebook
VP - Finance
Helen Tsui
  Helen Tsui LinkedIn Profile  Helen Tsui Twitter Account  Helen Tsui News  Helen Tsui on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/22/2012: 2nd Watch venture capital transaction
Next: 12/26/2012: Aura Biosciences venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary